— Know what they know.
Not Investment Advice

RAFA OTC

Rafarma Pharmaceuticals, Inc.
1W: -13.5% 1M: +6.7% 3M: +60.0% YTD: +17.0% 1Y: -33.3% 3Y: -86.1% 5Y: -97.4%
$0.03
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 54 · $2.8M mcap · Short 59% of daily vol

📊 Key Metrics

TTM
$9M
Revenue
-66.0% YoY
$0M
Net Income
-68.7% YoY
$-1M
Free Cash Flow
+95.4% YoY
42.8%
Gross Margin
29.5%
Op. Margin
26.6%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE2.9%
ROA2.5%
ROIC3.4%

Valuation

P/E13.9
P/B0.3
EV/EBITDA28.8

Leverage

Debt/Equity0.00
Current Ratio1.13
Interest Cov.0.0x

Quality Scores

Piotroski F3/9
Altman Z5.15
Beneish M-2.40

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms